BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38290775)

  • 41. Comparison of
    Wu J; Deng H; Zhong H; Wang T; Rao Z; Wang Y; Chen Y; Zhang C
    Front Oncol; 2022; 12():924223. PubMed ID: 35860594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Head-to-head comparison of [
    Ballal S; Yadav MP; Roesch F; Satapathy S; Moon ES; Martin M; Wakade N; Sheokand P; Tripathi M; Chandekar KR; Agarwal S; Sahoo RK; Rastogi S; Bal C
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):233-244. PubMed ID: 37642703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of [
    Kömek H; Can C; Kaplan İ; Gündoğan C; Kepenek F; Karaoglan H; Demirkıran A; Ebinç S; Güzel Y; Gündeş E
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3898-3909. PubMed ID: 35578038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance and Prospects of [
    Borgonje PE; Andrews LM; Herder GJM; de Klerk JMH
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Head-to-head Intra-individual Comparison of [
    Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
    Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
    Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
    Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Head-to-Head Comparison between [
    Ballal S; Yadav MP; Roesch F; Wakade N; Raju S; Sheokand P; Mishra P; Moon ES; Tripathi M; Martin M; Bal C
    Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the diagnostic efficacy of
    Zhang Z; Jia G; Pan G; Cao K; Yang Q; Meng H; Yang J; Zhang L; Wang T; Cheng C; Zuo C
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2877-2888. PubMed ID: 35243518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective comparison of
    Ding H; Liang J; Qiu L; Xu T; Cai L; Wan Q; Wang L; Liu Y; Chen Y
    Front Oncol; 2022; 12():1047010. PubMed ID: 36568172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The performance of
    Jiang Y; Wen B; Li C; Tian Y; Xiao Z; Xu K; Xing D; Yu Z; Huang J; Jia J; He Y
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2114-2126. PubMed ID: 36808001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis.
    Ruan D; Zhao L; Cai J; Xu W; Sun L; Li J; Zhang J; Chen X; Chen H
    Theranostics; 2023; 13(13):4694-4710. PubMed ID: 37649615
    [No Abstract]   [Full Text] [Related]  

  • 52. Biodistribution, pharmacokinetics, dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Dendl K; Koerber SA; Finck R; Mokoala KMG; Staudinger F; Schillings L; Heger U; Röhrich M; Kratochwil C; Sathekge M; Jäger D; Debus J; Haberkorn U; Giesel FL
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4089-4100. PubMed ID: 34050777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of [
    Jiang D; Chen X; You Z; Wang H; Zhang X; Li X; Ren S; Huang Q; Hua F; Guan Y; Zhao J; Xie F
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):732-742. PubMed ID: 34297193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.
    Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G
    Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A head-to-head comparison of
    Qin C; Liu F; Huang J; Ruan W; Liu Q; Gai Y; Hu F; Jiang D; Hu Y; Yang K; Lan X
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3228-3237. PubMed ID: 33609152
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Fu H; Wu J; Huang J; Sun L; Wu H; Guo W; Qiu S; Chen H
    Radiology; 2022 Aug; 304(2):397-405. PubMed ID: 35536131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Value of Semi-Quantitative Parameters of
    Li T; Liu Y; Dai M; Zhao X; Han J; Zhang Z; Jing F; Tian W; Zhang J; Zhao X; Wang J; Hao T; Wang T
    Cancer Biother Radiopharm; 2024 May; ():. PubMed ID: 38808470
    [No Abstract]   [Full Text] [Related]  

  • 59. Improved cancer detection in Waldeyer's tonsillar ring by
    Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.